SEVER Life Sciences, through its subsidiary Nordic Pharma, will showcase patient data and studies on LACRIFILL® Canalicular Gel, an innovative eye surface therapy, at the 2026 American Academy of Ophthalmology (AAO) Congress. The gel is used by over 2,200 ophthalmology and optometry offices in the U.S. for cataract and refractive surgery patients, as well as dry eye disease sufferers, with more than 130,000 patients treated to date. Recent surveys show high patient satisfaction, with 96% of cataract surgery patients and 91% overall reporting improved eye comfort. The presentation highlights LACRIFILL's benefits in post-surgical recovery and reducing dependence on eye drops, signaling potential growth and wider adoption in eye care.
The story about SEVER Life Sciences sharing patient data on LACRIFILL® Canalicular Gel is presented here with related market context. For readers following the Health sector, of 100 priced US stocks tradable on Pluang, 56 rose and 43 fell today. Notable movers include FLNA at USD 0.82 with a -6.28% change and 100% buy order activity, TXG at USD 75.62 with a -6.24% change, and RXRX at USD 4.35 with a -6.05% change and 79% sell order activity. These figures are as of Oct 07, 2026 21:21 WIB.
Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...
Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...
Barclays has lowered its price target for Netflix shares from $80 to $70 due to concerns over slower revenue growth and rising content costs, especially for live programming. Despite Netflix's large subscriber base of 325 million, the company faces p...
GLPI's focus on regional gaming assets helps reduce tenant performance volatility, shielding it from Las Vegas tourism downturns and supporting steady financial results. The company shows strong fundamentals with a discounted Price/AFFO ratio of 9.12...
After 15 years of near-zero interest rates, the US economy faces challenges as the 10-year Treasury yield exceeds 5%, the highest since 2002. This rise increases borrowing costs for corporations, homeowners, and the government, with $4.3 trillion in ...
